Reporter construct of GR (MR,PR,AR) response element, mutated
Alternative name | 2484C6F |
---|---|
Clone info. | mutant GR (MR,PR,AR) response element is cloned into the BglII site of phRL-TK, and the BglII site is killed by the cloning. The nucleotide sequence of the mutant GR (MR,PR,AR) response element is 5'-gatccagcccaaaatgaactg-3'. |
Comment | The nucleotide sequence of the element was determined. Function of the inserted element has not been examined by the depositor. |
Vector backbone | phRL-TK (Plasmid) |
Size of vector backbone | 4.0 kb |
Selectable markers | Amp^r |
Gene/insert name | Artificial GR (MR,PR,AR) response element, mutated synthesized |
Depositor|Developer | Yokoyama, Kazunari | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to expressly describe the acknowledgement of the Gene Engineering Division, RIKEN BRC as the source of the BIOLOGICAL RESOURCE in any publication. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit organization for a not-for-profit research. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | リソースを使用して論文を投稿する場合、理研BRC・遺伝子材料開発室から分譲された事を記載する。本件リソースは非営利機関にのみ提供し、非営利研究にのみ利用することができる。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05629 | pmutant GR RE-TK hRluc(F) | DNA solution |
Materials & Methods section:
The pmutant GR RE-TK hRluc(F) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05629). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB15034_A7Ecp1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: SV40pA3'Element Reverse Sequence file: RDB15034_A7Eca.seq |
---|
>05629_15034_A7Ec_Sv40pA3'ElementReverse_B04_04_ABI24.ab1 1 TACGCAGGGG GCGGAGCCTA TGGAAAACGC CAGCAACGCG GCCTTTTTAC GGTTCCTGGC 61 CTTTTGCTGG CCTTTTGCTC ACATGGCTCG ACAGATCCAG CCCAAAATGA ACTGGATCTA 121 AATGAGTCTT CGGACCTCGC GGGGGCCGCT TAAGCGGTGG TTAGGGTTTG TCTGACGCGG 181 GGGGAGGGGG AAGGAACGAA ACACTCTCAT TCGGAGGCGG CTCGGGGTTT GGTCTTGGTG 241 GCCACGGGCA CGCAGAAGAG CGCCGCGATC CTCTTAAGCA CCCCCCCGCC CTCCGTGGAG 301 GCGGGGGTTT GGTCGGCGGG TGGTAACTGG CGGGCCGCTG ACTCGGGCGG GTCGCGCGCC 361 CCAGAGTGTG ACCTTTTCGG TCTGCTCGCA GACCCCCGGG CGGCGCCGCC GCGGCGGCGA 421 CGGGCTCGCT GGGTCCTAGG CTCCATGGGG ACCGTATACG TGGACAGGCT CTGGAGCATC 481 CGCACGACTG CGGTGATATT ACCGGAGACC TTCTGCGGGA CGAGCCGGGT CACGCGGCTG 541 ACGCGGAGCG TCCGTTGGGC GACAAACACC AGGACGGGGC ACAGGTACAC TATCTTGTCA 601 CCCGGAGGCG CGAGGGACTG CAGGAGCTTC AGGGAGTGGC GCAGCTGCTT CATCCCCGTG 661 GCCCGTTGCT CGCGTTTGCT GGCGGTGTCC CCGGAAGAAA TATATTTGCA TGTCTTTAGT 721 TCTATGATGA CACAAACCCC GCCCAGCGTC TTGTCATTGG CGAATTCGAA CACGCAGATG 781 CAGTCGGGGC GGCGCGGTCC CAGGTCCACT TCGCATATTA AGGTGACGCG TGTGGCCTCG 841 AACACCGAGC GACCCTGCAG CGACCCGCTT AAAAGCTTGA TTCTTCTGAC ACAACAGTCT 901 CGAACTTAAG CTGCAGAAGT TGGTCGTGAG GCACTGGGCA GGTAAGTATC AAGGTTACAA 961 GACAGGTTTA AGGAGACCAA TAGAACTGGG CTTGTCGAGA CAGAGAAGAC TCTTGCGTTT 1021 CTGATAGGCA CCTATTGGTC TTACTGACAT CCACTTGCTT TCTCCTCCAC AGGTGTCCAC 1081 TCCCAGTCCA TACAGCTCTA AGGCTAGAGT ACCTATACGA CTCACTATAG GCTAGCCAAC 1141 CATGGACTTC CCGAGGGTGT TACCGAATCC A // |
Primer: pAxCALNL_F1 Sequence file: RDB15034_A7Ecb.seq |
>05629_15034_A7Ec_pAxCALNL_F1_C04_07_ABI24.ab1 1 ACTATATATC TTATCATGTC TGCTCGAAGC GGCCGCTCTA GAATTACTGC TCGTTCTTCA 61 GCACGCGCTC CACGAAGCTC TTGATGTACT TACCCATTTC ATCTGGAGCG TCCTCCTGGC 121 TGAAGTGGAG GCCCTTCACC TTCACGAACT CGGTGTTAGG GAACTTCTTA GCTCCCTCGA 181 CAATAGCGTT GGAAAAGAAC CCAGGGTCGG ACTCGATGAA CATCTTAGGC AGATCGTCGC 241 TGGCCCGAAG GTAGGCGTTG TAGTTGCGGA CAATCTGGAC GACGTCGGGC TTGCCTCCCT 301 TAACGAGAGG GATCTCGCGA GGCCAGGAGA GGGTAGGCCG TCTAACCTCG CCCTTCTCCT 361 TGAATGGCTC CAGGTAGGCA GCGAACTCCT CAGGCTCCAG TTTCCGCATG ATCTTGCTTG 421 GGAGCATGGT CTCGACGAAG AAGTTATTCT CAAGCACCAT TTTCTCGCCC TCTTCGCTCT 481 TGATCAGGGC GATATCCTCC TCGATGTCAG GCCACTCGTC CCAGGACTCG ATCACGTCCA 541 CGACACTCTC AGCATGGACG ATGGCCTTGA TCTTGTCTTG GTGCTCGTAG GAGTAGTGAA 601 AGGCCAGACA AGCCCCCCAG TCGTGGCCCA CAAAGATGAT TTTCTTTGGA AGGTTCAGCA 661 GCTCGAACCA AGCGGTGAGG TACTTGTAGT GATCCAGGAG GCGATATGAG CCATTCCCGC 721 TCTTGCCGGA CTTACCCATT CCGATCAGAT CAGGGATGAT GCATCTAGCC ACGGGCTCGA 781 TGTGAGGCAC GACGTGCCTC CACAGGTAGC TGGAGGCAGC GTTACCATGC AGAAAAATCA 841 CGGCGTTCTC GGCGTGCTTC TCGGAATCAT AGTAGTTGAT GAAGGAGTCC AGCACGTTCA 901 TTTGCTTGCA GCGAGCCCAC CACTGAGGCC CAGTGATCAT GCGTTTGCGT TGCTCGGGGT 961 CGTACACCTT GGAAAGCCAT GGTGGCTAGC CTATAGTGAG TCGTATTAAG TACTCTAGCC 1021 TTAAGAGCTG TAATTGAACT GGGGAGTGGA CACCTGGTGG GAGAGAACGC AAAGTGGATG 1081 TCAGTAGACC CAATAGTGCC TATCAGAACG CAGAGTCTTC CCTGGTCTCG ACAGCCAGTT 1141 CGATGGATCT CCTTAACCTG TTCTTGTGTT AACCCTGGAA TATACCT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content